Defects in the insulin/insulin-like growth factor signaling pathway (insulin/IGF signaling or IIS) manifest as a metabolic syndrome [95], a precursor to the onset of type 2 diabetes mellitus (T2DM) associated with an increased risk of some cancers. This evidence concerns the gene INS and cancer.